6
Participants
Start Date
December 13, 2023
Primary Completion Date
May 30, 2024
Study Completion Date
July 30, 2024
Pimicotinib(ABSK021)
A standard meal should be given to the subjects in the evening before dosing. Then, the subjects should fast for at least 10 hours. Water is not prohibited overnight. The next morning, the subjects should administer study drug in fasted state with warm water. The total volume of warm water and suspension is approximately 240 mL. Water is prohibited from 1 hour before dosing to 1 hour after dosing. No food is allowed within 4 hours after dosing. During the study, subjects will receive standardized meals at approximately the same time each day.
The First Affiliated Hospital of SOOCHOW UNIVERSITY, Suzhou
Lead Sponsor
Abbisko Therapeutics Co, Ltd
INDUSTRY